Literature DB >> 21388808

Synthesis and proteasome inhibition of lithocholic acid derivatives.

Zhao Dang1, Andrew Lin, Phong Ho, Dominique Soroka, Kuo-Hsiung Lee, Li Huang, Chin-Ho Chen.   

Abstract

A new class of proteasome inhibitors was synthesized using lithocholic acid as a scaffold. Modification at the C-3 position of lithocholic acid with a series of acid acyl groups yielded compounds with a range of potency on proteasome inhibition. Among them, the phenylene diacetic acid hemiester derivative (13) displayed the most potent proteasome inhibition with IC(50) = 1.9 μM. Enzyme kinetic analysis indicates that these lithocholic acid derivatives are noncompetitive inhibitors of the proteasome.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388808      PMCID: PMC3072167          DOI: 10.1016/j.bmcl.2011.02.041

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.

Authors:  N P Dantuma; K Lindsten; R Glas; M Jellne; M G Masucci
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

2.  Effect of noncompetitive proteasome inhibition on bortezomib resistance.

Authors:  Xiaoming Li; Tabitha E Wood; Remco Sprangers; Gerrit Jansen; Niels E Franke; Xinliang Mao; Xiaoming Wang; Yi Zhang; Sue Ellen Verbrugge; Hans Adomat; Zhi Hua Li; Suzanne Trudel; Christine Chen; Tomasz L Religa; Nazir Jamal; Hans Messner; Jacqueline Cloos; David R Rose; Ami Navon; Emma Guns; Robert A Batey; Lewis E Kay; Aaron D Schimmer
Journal:  J Natl Cancer Inst       Date:  2010-05-26       Impact factor: 13.506

Review 3.  Characterization of noncompetitive regulators of proteasome activity.

Authors:  Maria Gaczynska; Pawel A Osmulski
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

4.  TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors.

Authors:  Remco Sprangers; Xiaoming Li; Xinliang Mao; John L Rubinstein; Aaron D Schimmer; Lewis E Kay
Journal:  Biochemistry       Date:  2008-06-10       Impact factor: 3.162

Review 5.  Intracellular protein degradation in mammalian and bacterial cells.

Authors:  A L Goldberg; J F Dice
Journal:  Annu Rev Biochem       Date:  1974       Impact factor: 23.643

Review 6.  Intracellular protein degradation in mammalian and bacterial cells: Part 2.

Authors:  A L Goldberg; A C St John
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

7.  The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".

Authors:  Huanjie Yang; Guoqing Shi; Q Ping Dou
Journal:  Mol Pharmacol       Date:  2006-11-08       Impact factor: 4.436

8.  Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.

Authors:  Huanjie Yang; Di Chen; Qiuzhi Cindy Cui; Xiao Yuan; Q Ping Dou
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 9.  Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.

Authors:  Robert C Kane; Peter F Bross; Ann T Farrell; Richard Pazdur
Journal:  Oncologist       Date:  2003

10.  Activation and inhibition of the proteasome by betulinic acid and its derivatives.

Authors:  Li Huang; Phong Ho; Chin-Ho Chen
Journal:  FEBS Lett       Date:  2007-09-24       Impact factor: 4.124

View more
  3 in total

1.  Synthesis of Lithocholic Acid Derivatives as Proteasome Regulators.

Authors:  Zhao Dang; Kathy Jung; Keduo Qian; Kuo-Hsiung Lee; Li Huang; Chin-Ho Chen
Journal:  ACS Med Chem Lett       Date:  2012-08-15       Impact factor: 4.345

Review 2.  Oxidative stress, antioxidants and intestinal calcium absorption.

Authors:  Gabriela Diaz de Barboza; Solange Guizzardi; Luciana Moine; Nori Tolosa de Talamoni
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

3.  Synthesis and Anticancer Activity of Hybrid Molecules Based on Lithocholic and (5Z,9Z)-Tetradeca-5,9-dienedioic Acids Linked via Mono(di,tri,tetra)ethylene Glycol and α,ω-Diaminoalkane Units.

Authors:  Vladimir A D'yakonov; Regina A Tuktarova; Lilya U Dzhemileva; Svetlana R Ishmukhametova; Usein M Dzhemilev
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.